RSS Introduction
What is RSS?
RSS (Really Simple Syndication) is an easy way to keep updated on the news that's of interest to you. Instead of having to go to websites to see if there's a new story or feature, you can use RSS to tell you every time the news you want is updated.
How can I use RSS?
To use RSS, you need to get hold of an application called a news reader. There are many, from freeware to shareware to choose from. These readers display RSS information feeds from your chosen websites on your computer. All you have to do to get set up is to select an RSS feed from the list below.
RSS (Really Simple Syndication) is an easy way to keep updated on the news that's of interest to you. Instead of having to go to websites to see if there's a new story or feature, you can use RSS to tell you every time the news you want is updated.
How can I use RSS?
To use RSS, you need to get hold of an application called a news reader. There are many, from freeware to shareware to choose from. These readers display RSS information feeds from your chosen websites on your computer. All you have to do to get set up is to select an RSS feed from the list below.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Prostate Cancer | Regimens | Drugs |
Rare Cancers | Regimens | |
Renal Cell Carcinoma | Regimens | Drugs |
Skin Cancer | Regimens | Drugs |
Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- Clinical Applications of Liquid Biopsies in Cancer
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Immunotherapy in Glioblastoma: Peaks and Pits
- Opinion: Understanding the FDA's Take on Cannabidiol
- Investigational Antiandrogen Drug Delays Metastasis in CRPC
- Polymorphism in HSD3B1 as a Potential Prognostic Biomarker in Prostate Cancer
- Opioid Use and Cancer
- OS and PFS End Points Not Met in Phase 3 Trial of Pembrolizumab in Advanced HCC
- No Benefit Observed With Osimertinib Plus Durvalumab in EGFR-Mutated NSCLC
- Evidence of the Role of Circulating Insulin in Renal Cell Carcinoma Risk